scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48.
Scpharmaceuticals Inc. (SCPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 5,559,528 | $34,858,241 | 0.69% | |
| 2. | Rubric Capital Management David Rosen | 3,500,000 | $21,945,000 | +29% | 0.45% |
| 3. | AIGH Investment Partners Orin Hirschman | 3,106,795 | $19,479,605 | +41% | 7.7% |
| 4. | StemPoint Capital Michelle Ross | 567,211 | $3,556,413 | 0.94% | |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 500,000 | $3,135,000 | -33% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.25 | 762,380 | Large Shareholder | 5,328,328 | 2022-11-25 | Filing | |
| $3.91 | 5,000 | Director | 5,000 | 2021-12-03 | Filing | |
| $3.96 | 10,000 | Officer, Director | 46,962 | 2021-12-03 | Filing | |
| $8.65 | 578,034 | Large Shareholder | 578,034 | 2020-05-26 | Filing | |
| $8.65 | 231,200 | Large Shareholder | 231,200 | 2020-05-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.09 | 87,036 | Large Shareholder | 410,268 | 2022-10-10 | Filing | |
| $4.09 | 19,017 | Large Shareholder | 92,983 | 2022-10-10 | Filing | |
| $4.09 | 456,413 | Large Shareholder | 2,231,601 | 2022-10-10 | Filing | |
| $5.02 | 5,808 | Large Shareholder | 497,304 | 2022-10-06 | Filing | |
| $5.02 | 1,269 | Large Shareholder | 112,000 | 2022-10-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,863,439 | $11,683,762 | 0% | |
| 2. | 1,404,607 | $8,806,886 | 0.35% | |
| 3. | 1,393,525 | $8,737,402 | 0.04% | |
| 4. | 1,369,888 | $8,589,197 | 0% | |
| 5. | 1,200,647 | $7,528,057 | 1.99% |
News See All
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript
PJ Kelleher: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded.
Is SCPH A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Hedge Funds Warming Up To scPharmaceuticals Inc. (SCPH)
In this article we will take a look at whether hedge funds think scPharmaceuticals Inc. (NASDAQ:SCPH) is a good investment right now.
Here is What Hedge Funds Think About scPharmaceuticals Inc. (SCPH)
Does scPharmaceuticals Inc. (NASDAQ:SCPH) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
13G Filing: RA Capital Management and Scpharmaceuticals Inc (SCPH)
Scpharmaceuticals Inc (NASDAQ:SCPH): Peter Kolchinsky's RA Capital Management filed an amended 13D.
You can check out RA Capital Management's latest holdings and filings here.